Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Accumulated Expenses (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed Accumulated Expenses for 10 consecutive years, with $90625.0 as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 248.97% to $90625.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $90625.0, a 248.97% increase, with the full-year FY2025 number at $58208.0, up 74.38% from a year prior.
  • Accumulated Expenses was $90625.0 for Q4 2025 at Cannabis Suisse, up from $74505.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $209620.0 in Q1 2022 to a low of $675.0 in Q4 2022.
  • A 5-year average of $68815.4 and a median of $58208.0 in 2025 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: plummeted 99.61% in 2022, then surged 8561.04% in 2023.
  • Cannabis Suisse's Accumulated Expenses stood at $173620.0 in 2021, then tumbled by 99.61% to $675.0 in 2022, then soared by 8561.04% to $58462.0 in 2023, then plummeted by 55.58% to $25969.0 in 2024, then surged by 248.97% to $90625.0 in 2025.
  • Per Business Quant, the three most recent readings for CSUI's Accumulated Expenses are $90625.0 (Q4 2025), $74505.0 (Q3 2025), and $58208.0 (Q2 2025).